Copyright Reports & Markets. All rights reserved.

Global Olmesartan Medoxomil Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Olmesartan Medoxomil Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 20mg
    • 1.3.3 40mg
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Olmesartan Medoxomil Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital and Clinic
    • 1.4.3 Pharmacy
  • 1.5 Global Olmesartan Medoxomil Tablets Market Size & Forecast
    • 1.5.1 Global Olmesartan Medoxomil Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Olmesartan Medoxomil Tablets Sales Quantity (2021-2032)
    • 1.5.3 Global Olmesartan Medoxomil Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Daiichi Sankyo
    • 2.1.1 Daiichi Sankyo Details
    • 2.1.2 Daiichi Sankyo Major Business
    • 2.1.3 Daiichi Sankyo Olmesartan Medoxomil Tablets Product and Services
    • 2.1.4 Daiichi Sankyo Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Daiichi Sankyo Recent Developments/Updates
  • 2.2 Teva Pharmaceutical
    • 2.2.1 Teva Pharmaceutical Details
    • 2.2.2 Teva Pharmaceutical Major Business
    • 2.2.3 Teva Pharmaceutical Olmesartan Medoxomil Tablets Product and Services
    • 2.2.4 Teva Pharmaceutical Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Teva Pharmaceutical Recent Developments/Updates
  • 2.3 Glenmark Pharmaceuticals
    • 2.3.1 Glenmark Pharmaceuticals Details
    • 2.3.2 Glenmark Pharmaceuticals Major Business
    • 2.3.3 Glenmark Pharmaceuticals Olmesartan Medoxomil Tablets Product and Services
    • 2.3.4 Glenmark Pharmaceuticals Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Glenmark Pharmaceuticals Recent Developments/Updates
  • 2.4 Biocon
    • 2.4.1 Biocon Details
    • 2.4.2 Biocon Major Business
    • 2.4.3 Biocon Olmesartan Medoxomil Tablets Product and Services
    • 2.4.4 Biocon Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Biocon Recent Developments/Updates
  • 2.5 Lupin
    • 2.5.1 Lupin Details
    • 2.5.2 Lupin Major Business
    • 2.5.3 Lupin Olmesartan Medoxomil Tablets Product and Services
    • 2.5.4 Lupin Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Lupin Recent Developments/Updates
  • 2.6 Sun Pharmaceutical
    • 2.6.1 Sun Pharmaceutical Details
    • 2.6.2 Sun Pharmaceutical Major Business
    • 2.6.3 Sun Pharmaceutical Olmesartan Medoxomil Tablets Product and Services
    • 2.6.4 Sun Pharmaceutical Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sun Pharmaceutical Recent Developments/Updates
  • 2.7 Mylan
    • 2.7.1 Mylan Details
    • 2.7.2 Mylan Major Business
    • 2.7.3 Mylan Olmesartan Medoxomil Tablets Product and Services
    • 2.7.4 Mylan Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Mylan Recent Developments/Updates
  • 2.8 CR Double-Crane
    • 2.8.1 CR Double-Crane Details
    • 2.8.2 CR Double-Crane Major Business
    • 2.8.3 CR Double-Crane Olmesartan Medoxomil Tablets Product and Services
    • 2.8.4 CR Double-Crane Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 CR Double-Crane Recent Developments/Updates
  • 2.9 Beijing Foyou Pharmaceutical
    • 2.9.1 Beijing Foyou Pharmaceutical Details
    • 2.9.2 Beijing Foyou Pharmaceutical Major Business
    • 2.9.3 Beijing Foyou Pharmaceutical Olmesartan Medoxomil Tablets Product and Services
    • 2.9.4 Beijing Foyou Pharmaceutical Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Beijing Foyou Pharmaceutical Recent Developments/Updates
  • 2.10 Zhejiang NuoDe Pharmaceutical
    • 2.10.1 Zhejiang NuoDe Pharmaceutical Details
    • 2.10.2 Zhejiang NuoDe Pharmaceutical Major Business
    • 2.10.3 Zhejiang NuoDe Pharmaceutical Olmesartan Medoxomil Tablets Product and Services
    • 2.10.4 Zhejiang NuoDe Pharmaceutical Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Zhejiang NuoDe Pharmaceutical Recent Developments/Updates
  • 2.11 Chongqing Kerui Pharmaceutical
    • 2.11.1 Chongqing Kerui Pharmaceutical Details
    • 2.11.2 Chongqing Kerui Pharmaceutical Major Business
    • 2.11.3 Chongqing Kerui Pharmaceutical Olmesartan Medoxomil Tablets Product and Services
    • 2.11.4 Chongqing Kerui Pharmaceutical Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Chongqing Kerui Pharmaceutical Recent Developments/Updates
  • 2.12 Bright Future Pharmaceutical
    • 2.12.1 Bright Future Pharmaceutical Details
    • 2.12.2 Bright Future Pharmaceutical Major Business
    • 2.12.3 Bright Future Pharmaceutical Olmesartan Medoxomil Tablets Product and Services
    • 2.12.4 Bright Future Pharmaceutical Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Bright Future Pharmaceutical Recent Developments/Updates
  • 2.13 Buchang Pharma
    • 2.13.1 Buchang Pharma Details
    • 2.13.2 Buchang Pharma Major Business
    • 2.13.3 Buchang Pharma Olmesartan Medoxomil Tablets Product and Services
    • 2.13.4 Buchang Pharma Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Buchang Pharma Recent Developments/Updates
  • 2.14 Qilu Pharmaceutical
    • 2.14.1 Qilu Pharmaceutical Details
    • 2.14.2 Qilu Pharmaceutical Major Business
    • 2.14.3 Qilu Pharmaceutical Olmesartan Medoxomil Tablets Product and Services
    • 2.14.4 Qilu Pharmaceutical Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Qilu Pharmaceutical Recent Developments/Updates
  • 2.15 Chia Tai-Tianqing Pharmaceutical
    • 2.15.1 Chia Tai-Tianqing Pharmaceutical Details
    • 2.15.2 Chia Tai-Tianqing Pharmaceutical Major Business
    • 2.15.3 Chia Tai-Tianqing Pharmaceutical Olmesartan Medoxomil Tablets Product and Services
    • 2.15.4 Chia Tai-Tianqing Pharmaceutical Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
  • 2.16 Shenzhen Salubris Pharmaceuticals
    • 2.16.1 Shenzhen Salubris Pharmaceuticals Details
    • 2.16.2 Shenzhen Salubris Pharmaceuticals Major Business
    • 2.16.3 Shenzhen Salubris Pharmaceuticals Olmesartan Medoxomil Tablets Product and Services
    • 2.16.4 Shenzhen Salubris Pharmaceuticals Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Shenzhen Salubris Pharmaceuticals Recent Developments/Updates
  • 2.17 Chengdu Brilliant Pharmaceutical
    • 2.17.1 Chengdu Brilliant Pharmaceutical Details
    • 2.17.2 Chengdu Brilliant Pharmaceutical Major Business
    • 2.17.3 Chengdu Brilliant Pharmaceutical Olmesartan Medoxomil Tablets Product and Services
    • 2.17.4 Chengdu Brilliant Pharmaceutical Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Chengdu Brilliant Pharmaceutical Recent Developments/Updates
  • 2.18 Zhuhai Rundu Pharmaceutical
    • 2.18.1 Zhuhai Rundu Pharmaceutical Details
    • 2.18.2 Zhuhai Rundu Pharmaceutical Major Business
    • 2.18.3 Zhuhai Rundu Pharmaceutical Olmesartan Medoxomil Tablets Product and Services
    • 2.18.4 Zhuhai Rundu Pharmaceutical Olmesartan Medoxomil Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Zhuhai Rundu Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Olmesartan Medoxomil Tablets by Manufacturer

  • 3.1 Global Olmesartan Medoxomil Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Olmesartan Medoxomil Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Olmesartan Medoxomil Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Olmesartan Medoxomil Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Olmesartan Medoxomil Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Olmesartan Medoxomil Tablets Manufacturer Market Share in 2025
  • 3.5 Olmesartan Medoxomil Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Olmesartan Medoxomil Tablets Market: Region Footprint
    • 3.5.2 Olmesartan Medoxomil Tablets Market: Company Product Type Footprint
    • 3.5.3 Olmesartan Medoxomil Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Olmesartan Medoxomil Tablets Market Size by Region
    • 4.1.1 Global Olmesartan Medoxomil Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Olmesartan Medoxomil Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Olmesartan Medoxomil Tablets Average Price by Region (2021-2032)
  • 4.2 North America Olmesartan Medoxomil Tablets Consumption Value (2021-2032)
  • 4.3 Europe Olmesartan Medoxomil Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Olmesartan Medoxomil Tablets Consumption Value (2021-2032)
  • 4.5 South America Olmesartan Medoxomil Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Olmesartan Medoxomil Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Olmesartan Medoxomil Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Olmesartan Medoxomil Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Olmesartan Medoxomil Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Olmesartan Medoxomil Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Olmesartan Medoxomil Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Olmesartan Medoxomil Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Olmesartan Medoxomil Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Olmesartan Medoxomil Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Olmesartan Medoxomil Tablets Market Size by Country
    • 7.3.1 North America Olmesartan Medoxomil Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Olmesartan Medoxomil Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Olmesartan Medoxomil Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Olmesartan Medoxomil Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Olmesartan Medoxomil Tablets Market Size by Country
    • 8.3.1 Europe Olmesartan Medoxomil Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Olmesartan Medoxomil Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Olmesartan Medoxomil Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Olmesartan Medoxomil Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Olmesartan Medoxomil Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Olmesartan Medoxomil Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Olmesartan Medoxomil Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Olmesartan Medoxomil Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Olmesartan Medoxomil Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Olmesartan Medoxomil Tablets Market Size by Country
    • 10.3.1 South America Olmesartan Medoxomil Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Olmesartan Medoxomil Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Olmesartan Medoxomil Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Olmesartan Medoxomil Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Olmesartan Medoxomil Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Olmesartan Medoxomil Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Olmesartan Medoxomil Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Olmesartan Medoxomil Tablets Market Drivers
  • 12.2 Olmesartan Medoxomil Tablets Market Restraints
  • 12.3 Olmesartan Medoxomil Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Olmesartan Medoxomil Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Olmesartan Medoxomil Tablets
  • 13.3 Olmesartan Medoxomil Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Olmesartan Medoxomil Tablets Typical Distributors
  • 14.3 Olmesartan Medoxomil Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Olmesartan Medoxomil Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Olmesartan Medoxomil Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Olmesartan Medoxomil Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Olmesartan Medoxomil Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Olmesartan Medoxomil Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Olmesartan Medoxomil Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Olmesartan Medoxomil Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Olmesartan Medoxomil Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Daiichi Sankyo, Teva Pharmaceutical, Glenmark Pharmaceuticals, Biocon, Lupin, Sun Pharmaceutical, Mylan, CR Double-Crane, Beijing Foyou Pharmaceutical, Zhejiang NuoDe Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Olmesartan Medoxomil Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    20mg
    40mg
    Others
    Market segment by Application
    Hospital and Clinic
    Pharmacy
    Major players covered
    Daiichi Sankyo
    Teva Pharmaceutical
    Glenmark Pharmaceuticals
    Biocon
    Lupin
    Sun Pharmaceutical
    Mylan
    CR Double-Crane
    Beijing Foyou Pharmaceutical
    Zhejiang NuoDe Pharmaceutical
    Chongqing Kerui Pharmaceutical
    Bright Future Pharmaceutical
    Buchang Pharma
    Qilu Pharmaceutical
    Chia Tai-Tianqing Pharmaceutical
    Shenzhen Salubris Pharmaceuticals
    Chengdu Brilliant Pharmaceutical
    Zhuhai Rundu Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Olmesartan Medoxomil Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Olmesartan Medoxomil Tablets, with price, sales quantity, revenue, and global market share of Olmesartan Medoxomil Tablets from 2021 to 2026.
    Chapter 3, the Olmesartan Medoxomil Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Olmesartan Medoxomil Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Olmesartan Medoxomil Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Olmesartan Medoxomil Tablets.
    Chapter 14 and 15, to describe Olmesartan Medoxomil Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now